Day 1 ASH: It’s All About Immunotherapy

Jack Aiello |

Dec 5, 2020 Today I actually began watching ASH (American Society of Hematology) President Dr. Stephanie Lee interview Dr. Fauci. I appreciated that one of the questions she asked was “Should cancer patients with compromised immune systems get the vaccine?” He said that he understands that cancer patients may actually be getting immunosuppressants, and the […]

Virtual ASH 2020: Don’t Stand So Close To Me

Michael Tuohy |

It’s the year 2020 which is a notable year for reasons beside being a global pandemic. For me, 2020 marks my 20th year of survival with multiple myeloma. I am deeply grateful for all the research that has taken place and hopeful for the future of myeloma, all while waiting for a cure. In 2000, […]

The End of 2020…..PLEASE!!

Jim Omel |

What a year we have endured! 2020 will be one of the darkest years in history for the USA ,similar to the turmoil and strife of 1968, an unforgettable year those of us old enough to remember it. Actually, our comparator for “worst year” must go back further than 1968; however, to a time none of […]

Twenty-five – Twenty-five

Yelak Biru |

When I was diagnosed with myeloma at age 25 and was told “You have myeloma. It is incurable but it is highly treatable. Come to my office tomorrow, and we will discuss your options.”  And when, soon after that, I was told the life expectancy of myeloma patients is 2-3 years. Or, with outstanding response […]

A Strange Year For Sure

Sheri Baker |

What a strange year this has been for all of us. Our lives have been full of virtual meetings for work and school as well as the safest way to get together with family and friends. The 62nd American Society of Hematology Annual Meeting (ASH) will be no different. ASH will be an all-virtual meeting this year. […]

All Virtual, All-Amazing

Jack Aiello |

There is no other single conference where so much information is presented about myeloma. Information about so many topics is provided:  how to treat MM patients in various stages; results of phase II & III trials which may indicate upcoming FDA approvals; pre-clinical research focusing on myeloma targets and cell understanding; and more. However, this year […]

Greetings from New Jersey

Cynthia Chmielewski |

This year the American Society of Hematology’s annual meeting will be held virtually.  I am getting accustomed to attending virtual events since all my meeting since the first week of March have been switched to this format. Virtual meetings have advantages and disadvantages.  Attending a scientific meeting from the comfort of your home is logistically […]